Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials
- PMID: 36541849
- PMCID: PMC9827545
- DOI: 10.15252/embr.202256184
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials
Abstract
In light of the pending antibiotic resistance crisis, we need to go back to nature and search for novel anti-bacterial compounds.
© 2022 The Authors. Published under the terms of the CC BY NC ND 4.0 license.
Figures




References
-
- Baumann S, Herrmann J, Raju R, Steinmetz H, Mohr KI, Hüttel S, Harmrolfs K, Stadler M, Müller R (2014) Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. Angew Chem Int Ed 53: 14605–14609 - PubMed
-
- Garcia R, Gerth K, Stadler M, Dogma IJ Jr, Müller R (2010) Expanded phylogeny of myxobacteria and evidence for cultivation of the ‘unculturables’. Mol Phylogenet Evol 57: 878–887 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical